Modified Release Community

 View Only

Question regarding a key component used in a subcutaneous Keytruda

  • 1.  Question regarding a key component used in a subcutaneous Keytruda

    Posted 04-15-2025 09:36

    A subcutaneous injection version of Keytruda is being developed as a patient-friendly option compared to the infusion product. This product includes a component called berahyaluronidase alfa to enhance the delivery dose via this route. How does berahyaluronidase alfa work?



    ------------------------------
    Madhulika Banerjee
    Student
    University of Pittsburgh
    Pittsburgh PA
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
    ------------------------------